Table 1 Index cases were classified as new VL cases, relapsed VL cases, VL treatment failure, or PKDL
720 contacts N (%) | 69 asymptomatic N (%) | |
|---|---|---|
Median age (IQR) | 27 (25) | 30 (25) |
Male | 280 (38.9) | 31 (44.9) |
Occupation | ||
Students | 248 (34.4) | 23 (33.3) |
Housewives | 301.68 (41.9) | 26 (37.7) |
Lives within the household of an index case | 505 (70.1) | 50 (72.5) |
VL | 476 (66.1) | 34 (49.3) |
New VL case | 429/476 (90.1) | 34/34 (100.0) |
Relapsed VL case | 45/476 (9.5) | 0 |
VL treatment failure | 2/476 (0.4) | 0 |
Post–kala azar dermal leishmaniasis (PKDL) | 244 (33.9) | 35 (50.7) |
Macular rash | 230/244 (95.0) | 33/35 (94.3) |
Macular and papular rash | 4/244 (1.7) | 0 |
Nodular and macular rash | 6/244 (2.5) | 0 |
Macular, nodular, and papular rash | 2/244 (0.8) | 1/35 (2.9) |
Rash type unknown | 2/244 (0.8) | 1/35 (2.9) |